RARE Drug Development Symposium: Artificial Intelligence and Machine Learning for Rare Disease

Dr. Annastasiah Mhaka, Dr. Swagatam Mukhopadhyay, and Dr. Harsha Rajasimha discuss the challenges and benefits of using artificial intelligence and machine learning in data research. While these tools can allow us to do more with less data, there are certain aspects of the research that cannot be duplicated by AI or ML.